1EQ
5HT
ACHBP
ACHBP RESULT
AR
AR
ADDITIONAL INFORMATION
AGONIST
B SUBUNIT
BECKMAN JA20 ROTOR
BINDING ASSAY TRANSFECTED CELL
BMAX
BMAX
CA
CA
CT
CACL
CHENG-PRUSOFF EQUATION
CI/MMOL
D-MEM
DMF
DATAPAC
E LOOP
E LOOP REGION
NICOTINIC ACHR E LOOP REGION
EC
EC50
ELECTROPHYSIOLOGICAL METHOD
TRANSFECTED TSA201 CELL ELECTROPHYSIOLOGICAL METHOD
FETAL           BOVINE SERUM
FLASH CHROMATOGRAPHY
FUNCTIONAL ACTIVITY
LERISETRON WHOLE CELL PATCH-CLAMP EXPERIMENT FUNCTIONAL ACTIVITY
FUNCTIONAL GROUP INTERACTION
Y152 FUNCTIONAL GROUP INTERACTION
FUNCTIONAL GROUP
GF/B FILTER
GRAPHPAD PRISM
GRAPHPAD PRISM
HEK293 CELL LINE
HRM
HETEROMERIC RECEPTOR
IC
IC
IC
IDENTIFICATION
INHIBITED RESPONSE
KI
KN
L102
LIGAND GATED ION CHANNELS
LGIC FAMILY
LGIC RECEPTOR
LGIC RECEPTOR
LGIC RECEPTOR
LGIC RECEPTOR
LGIC RECEPTOR
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LOWRY ASSAY
M114
MDL-72222
M
MGCL
MGCL
MUTAGENESIS STUDY
MΩ
N-BENZYL
N-BENZYL
FUNCTIONAL GROUP N-BENZYL
N-BENZYL GROUP
N-BENZYL GROUP
N-BENZYL GROUP
N-BENZYL GROUP
N-BENZYL GROUP
N-BENZYL GROUP
N-BENZYL GROUP
N-BENZYL GROUP
N-BENZYL GROUP
N-BENZYL GROUP
N-BENZYL GROUP
LERISETRON N-BENZYL GROUP
N-BENZYL INTERACTION
N1 POSITION
BENZIMIDAZOLE N1 POSITION
NEN
NEN
NMR
NY
NY
NAH
NUCLEAR
ORJALE
ORJALE
ORJALE
PHOSPHATE BUFFERED SALINE
PHOSPHATE BUFFERED SALINE
PHOSPHATE BUFFERED SALINE
PHOSPHATE BUFFERED SALINE
PENICILLIN-STREPTOMYCIN
PREVIOUS STUDY
PROTEIN CONTENT
Q55
QIAGEN
QIAGEN SUPERFECT TRANSFECTION REAGENT
R ANTAGONIST
R ANTAGONIST GRANISETRON
R ANTAGONIST
R LIGAND
R LIGAND
R RECEPTOR
R104
R91
R91
R91
R91
R91
R91
R91
R91 Y140
RBI
RADIOLIGAND
BINDING ASSAY TRANSFECTED CELL RADIOLIGAND
REACTION PRODUCT
RECENT STUDY
R
R
R
SAN DIEGO CA
SAN DIEGO CA
SEQUENCE ALIGNMENT
SIGMA
ST
TLC
TRANSFECTED CELL
TRANSFECTED TSA201 CELL
TRYPSIN
W53
W89
W89
W89
W89
W89
W89
W89
W89
W89
W89
W89
W89
W89
W89
W89 INTERACTION
W89 RELATIVE
Y140
Y140
Y140
Y140
Y140
Y142
Y142
Y142
Y142
Y142
Y142
Y142
Y142
Y142
Y142
Y142
Y152
Y152
Y152
Y152
Y152
Y152
Y152
Y152
Y152
Y152
Y152
Y152
Y152
Y152
5HT Y152
Y93
Y93
ABILITY
ABSENCE
ABSENCE
N-BENZYL GROUP ABSENCE
ACETYLCHOLINE BINDING DOMAIN
ACETYLCHOLINE RECEPTOR
ACID
ACID
ACID
ACID
ACID
ACID
ACID INTERACTION
AFFINITY
AFFINITY
AGONIST
AGONIST ACTIVITY
AGONIST APPLICATION
ALANINE SUBSTITUTION
ALANINE SUBSTITUTION
ALANINE SUBSTITUTION
ALKYL BROMIDE
ANTAGONIST PHARMACOPHORE
ANXIETY
AROMATIC AMINO ACID
AROMATIC BENZIMIDAZOLE
AROMATIC BENZIMIDAZOLE
AROMATIC BENZIMIDAZOLE GROUP
LERISETRON AROMATIC BENZIMIDAZOLE GROUP
AROMATIC RING
AROMATIC RING
AROMATIC RING
ATMOSPHERE
BENZIMIDAZOLE
BENZIMIDAZOLE
BENZIMIDAZOLE GROUP
BENZIMIDAZOLE HETEROCYCLE
BENZIMIDAZOLE PORTION
LERISETRON BENZIMIDAZOLE PORTION
BENZYL GROUP
BINDING PROTEIN
BIOISOSTERE
BIOISOSTERIC EQUIVALENT
BONDING INTERACTION
CALCIUM PHOSPHATE CO-PRECIPITATION
CARBONYL GROUP
CARBONYL OXYGEN
CARBONYL OXYGEN
CATION-Π INTERACTION
CATION-Π INTERACTION
CHANGE DIFFERED
CHROMATOGRAPHY
CO-EXPOSURE
COMPETITIVE ANTAGONIST ACTION
LERISETRON COMPETITIVE ANTAGONIST ACTION
COMPLEMENTARY FACE
COMPOUND
COMPOUND
COMPOUND
COMPOUND
COMPOUND (1-(PHENYLMETHYL)-2-PIPERIZINYL BENZIMIDAZOLE
COMPUTER CONTROL
CONCENTRATION
CONCENTRATION
CONCENTRATION
CONCENTRATION L
CONTAINING MUTATION
CRITICAL DISULFIDE LOOP STRUCTURE
CRYSTALLIZATION
CYSTEINE-LOOP FAMILY
LIGAND CYSTEINE-LOOP FAMILY
DERIVATIVE
HEK293 CELL LINE DERIVATIVE
DETERMINATION
DETERMINATION
DETERMINATION
DETERMINATION
DISTAL AMINO
DISTAL AMINO GROUP
DISTAL AMINO NITROGEN
DISTAL AMINO NITROGEN
DISTAL NITROGEN
DISTAL PIPERAZINE NITROGEN
DISTAL PIPERAZINE NITROGEN
DISTAL PIPERAZINE NITROGEN
DISTAL PIPERAZINE NITROGEN
DISTAL PIPERAZINE NITROGEN
DISTAL PIPERAZINE NITROGEN
LERISETRON DISTAL PIPERAZINE NITROGEN
ELECTROSTATIC INTERACTION
ELEMENTAL ANALYSIS
EMESI
EMESI
ENERGY
EQUILIBRIUM L
EXTRACELLULAR RECORDING BUFFER
EXTRACELLULAR SOLUTION
FETAL BOVINE SERUM
FINAL STEP
FORMING INTERACTION
FRACTION
FRACTIONAL AMOUNT
FUNCTIONAL ACTIVITY
LERISETRON FUNCTIONAL ACTIVITY
FUNCTIONAL GROUP
FUNCTIONAL GROUP
FUNCTIONAL GROUP
FUNCTIONAL GROUP
FUNCTIONAL GROUP INTERACTION
MCPBG FUNCTIONAL GROUP INTERACTION
FUNCTIONAL GROUP
FUNCTIONAL GROUP
FUNCTIONAL GROUP
LERISETRON FUNCTIONAL GROUP
FUNCTIONAL HOMOMERIC RECEPTOR
GLYCINE
GLYCINE RECEPTOR
GRANISETRON
GRANISETRON
GRANISETRON
GRANISETRON
GRANISETRON
GRANISETRON
GRANISETRON
GROUP INTERACTING
HETEROMERIC RECEPTOR
HOLDING POTENTIAL
HOMOGENATE
HOMOGENATE
HOMOGENIZED
HOMOLOGY
HYDROGEN
BONDING INTERACTION HYDROGEN
HYPOTHETICAL MODEL
LERISETRON-BINDING SITE HYPOTHETICAL MODEL
INHIBITION EXPERIMENT
INHIBITION EXPERIMENT
INTEGRAL ION
SELECTIVE CHANNEL INTEGRAL ION
INTERACTION
INTRACELLULAR RECORDING BUFFER
INVESTIGATION
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON
LERISETRON WHOLE CELL PATCH-CLAMP EXPERIMENT
LERISETRON BINDING
LERISETRON BINDING
LERISETRON BINDING
LERISETRON BINDING
LERISETRON INHIBITION
LERISETRON MOLECULE
LERISETRON-BINDING SITE
LIGAND
LIGAND
LIGAND
LIGAND
LIGAND
LIGAND CONCENTRATION
LIPOPHILIC REGION
LITERATURE REPORT
MCPBG
MM EGTA
MM HEPE
MM HEPE
PH MM HEPE
PH MM HEPE
MM KCL
MM KCL
MM NACL
MAXIMAL ACTIVATION
METHYLENE CHLORIDE
MIN
ML PB
ML PB
MODIFICATION
MOLECULAR MODELING
MOLECULE
MOLECULE
MOLECULE
MOLECULE
MUTAGENESIS DATA
MUTAGENESIS STUDY
MUTANT RECEPTOR
NM
LERISETRON INHIBITION NM
NICOTINIC ACHR
NICOTINIC ACETYLCHOLINE
BINDING PROTEIN NICOTINIC ACETYLCHOLINE
NICOTINIC ACETYLCHOLINE RECEPTOR
NITROGEN
NITROGEN
NITROGEN
NITROGEN
NITROGEN
PIPERAZINE RING NITROGEN
NUCLEOPHILIC SUBSTITUTION
OBSERVATION
ONSET ALCOHOLISM
ORGANIC LAYER
OXYGEN
PH
PH
PENTAMERIC QUATERNARY STRUCTURE
PHARMACOPHORE MODEL
PHARMACOPHORIC REGION
PIPERAZINE
PIPERAZINE
PIPERAZINE NITROGEN
PIPERAZINE NITROGEN
PIPERAZINE NITROGEN
PIPERAZINE RING
PIPERAZINE RING
POINT INTERACTION
POTENTIAL APPLICATION
POTENTIAL INTERACTION
POTENTIAL INTERACTION
N-BENZYL GROUP POTENTIAL INTERACTION
PRINCIPAL FACE
PRODUCED INCREASE
PROTEIN
PROTEIN HOMOLOGOUS
PUTATIVE BINDING SITE RESIDUE
PUTATIVE INTERACTION
RAPID FILTRATION
RAPID PERFUSION SYSTEM
REACTION MIXTURE
RECEPTOR
RECEPTOR
RECEPTOR
RECEPTOR
RECEPTOR FAMILY
RECEPTOR
RECORDING CHAMBER
REFLUX
REGION HOMOLOGUS
REORIENTATION
MOLECULE REORIENTATION
RESIDUES LINE
RESPONSE PROFILE
ROOM TEMPERATURE
SECONDARY STRUCTURE
SELECTIVE CHANNEL
SEQUENCE ALIGNMENT
STOICHIOMETRY
STRUCTURAL INFORMATION
STRUCTURAL PREDICTION
STRUCTURAL SIMILARITY
STRUCTURAL SIMILARITY
STRUCTURE-ACTIVITY RELATIONSHIP STUDY
SUBJECT
SUBSTITUTION
SUBSTITUTION
SUBSTITUTION
OXYGEN SUBSTITUTION
DISTAL AMINO NITROGEN OXYGEN SUBSTITUTION
DISTAL AMINO NITROGEN SUBSTITUTION
PIPERAZINE NITROGEN SUBSTITUTION
SUBTYPE
SUBTYPE
SUBUNIT
SUBUNIT
SUBUNIT
SUBUNIT
SUBUNIT INTERFACE
TARGET MOLECULE
TRANSFECTION
TSA201 CELL TRANSFECTION
TSA201 CELL
TSA201 CELL
TSA201 CELL
TYPE RECEPTOR
UNKNOWN
VACUUM
VARYING CONCENTRATION
VARYING CONCENTRATION
WILDTYPE
WORKING HYPOTHESIS
WT RECEPTOR
Β-SHEET
Β-STRAND
Γ-AMINO BUTYRIC ACID TYPE
ΜM MDL-72222
ΜM MCPBG
ΜL
ΜL
HOMOGENATE ΜL
HOMOGENATE ΜL
LIGAND GATED ION CHANNELS
LGIC
Γ-AMINO BUTYRIC ACID TYPE A
GABA
GLYR
TO ALANINE
R91A
5-HYDROXYTRYPTAMINE
5-HT
results
INFORMATION
SUBUNIT
BINDING ASSAY TRANSFECTED
TRANSFECTED
equations
ELECTROPHYSIOLOGICAL
CHROMATOGRAPHY
FUNCTIONAL GROUP
cell lines
INTERACTION
positions
contents
QIAGEN
TRANSFECTION
antagonists
R ANTAGONIST
ANTAGONIST GRANISETRON
RECEPTOR
Y140
REACTION
products
DIEGO CA
DIEGO CA
alignments
TRANSFECTED TSA201
TRANSFECTED
TSA201
INTERACTION
binding domains
INTERACTION
applications
SUBSTITUTION
SUBSTITUTION
SUBSTITUTION
antagonists
PHARMACOPHORE
BENZIMIDAZOLE
BENZIMIDAZOLE
BENZIMIDAZOLE GROUP
HETEROCYCLE
INTERACTION
INTERACTION
INTERACTION
changes
competitive antagonist
ANTAGONIST ACTION
faces
(1-(PHENYLMETHYL)-2-PIPERIZINYL BENZIMIDAZOLE
controls
CONCENTRATION
PIPERAZINE NITROGEN
PIPERAZINE NITROGEN
PIPERAZINE NITROGEN
PIPERAZINE NITROGEN
PIPERAZINE NITROGEN
PIPERAZINE NITROGEN
INTERACTION
analyses
RECORDING BUFFER
solution
bovine serum
steps
FUNCTIONAL GROUP
FUNCTIONAL HOMOMERIC
homomeric
RECEPTOR
RECEPTOR
inhibition
inhibition
RECORDING BUFFER
inhibition
CONCENTRATION
EGTA
KCL
KCL
NACL
activation
ACHR
NICOTINIC
acetylcholine
ACETYLCHOLINE RECEPTOR
SUBSTITUTION
layers
quaternary structure
PHARMACOPHORIC
applications
faces
homologous
INTERACTION
filtration
PERFUSION SYSTEM
REACTION
mixtures
RECEPTOR
RECORDING
HOMOLOGUS
lines
responses
profiles
alignments
INFORMATION
similarities
similarities
STRUCTURE-ACTIVITY RELATIONSHIP
targets
TSA201
TSA201
TSA201
RECEPTOR
